CA1048933A - Pharmaceutical preparations for the treatment of hyperuricacidemia - Google Patents
Pharmaceutical preparations for the treatment of hyperuricacidemiaInfo
- Publication number
- CA1048933A CA1048933A CA76253650A CA253650A CA1048933A CA 1048933 A CA1048933 A CA 1048933A CA 76253650 A CA76253650 A CA 76253650A CA 253650 A CA253650 A CA 253650A CA 1048933 A CA1048933 A CA 1048933A
- Authority
- CA
- Canada
- Prior art keywords
- allopurinol
- benzbromaron
- preparation according
- dosage unit
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19752555609 DE2555609A1 (de) | 1975-12-10 | 1975-12-10 | Pharmazeutisches praeparat zur therapie der hyperurikaemie |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1048933A true CA1048933A (en) | 1979-02-20 |
Family
ID=5964014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA76253650A Expired CA1048933A (en) | 1975-12-10 | 1976-05-28 | Pharmaceutical preparations for the treatment of hyperuricacidemia |
Country Status (8)
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005046724A1 (ja) | 2003-11-14 | 2005-05-26 | Human Cell Systems, Inc. | 血管障害や高血圧症の治療・予防剤、及びそのスクリーニング方法 |
WO2005082840A1 (ja) | 2004-03-01 | 2005-09-09 | Japan Science And Technology Agency | N-アシルヒドラゾンのアリル化方法 |
JP2008506785A (ja) * | 2004-07-21 | 2008-03-06 | フロリダ大学 リサーチファウンデーション インコーポレイティッド | インスリン抵抗性の治療及び予防のための組成物及び方法 |
WO2012048058A2 (en) * | 2010-10-06 | 2012-04-12 | J-Pharma Co., Ltd. | Developing potent urate transporter inhibitors: compounds designed for their uricosuric action |
CN103242272B (zh) * | 2013-05-22 | 2016-01-27 | 合肥医工医药有限公司 | 一种制备苯溴马隆的方法 |
-
1975
- 1975-12-10 DE DE19752555609 patent/DE2555609A1/de active Pending
-
1976
- 1976-05-11 GB GB19223/76A patent/GB1493237A/en not_active Expired
- 1976-05-24 NL NL7605531A patent/NL7605531A/xx not_active Application Discontinuation
- 1976-05-24 ZA ZA763081A patent/ZA763081B/xx unknown
- 1976-05-28 CA CA76253650A patent/CA1048933A/en not_active Expired
- 1976-05-31 BE BE167474A patent/BE842389A/xx not_active IP Right Cessation
- 1976-06-01 FR FR7616454A patent/FR2334362A1/fr active Granted
- 1976-06-29 AU AU15413/76A patent/AU505476B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
AU1541376A (en) | 1978-01-05 |
NL7605531A (nl) | 1977-06-14 |
FR2334362B1 (US06299757-20011009-C00006.png) | 1979-08-24 |
DE2555609A1 (de) | 1977-06-30 |
FR2334362A1 (fr) | 1977-07-08 |
AU505476B2 (en) | 1979-11-22 |
ZA763081B (en) | 1977-04-27 |
GB1493237A (en) | 1977-11-30 |
BE842389A (fr) | 1976-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2140266C1 (ru) | Фармацевтическая композиция с регулируемым выделением на основе одной или нескольких фармацевтически приемлемых солей гамма-гидроксимасляной кислоты и способ ее получения | |
AU597471B2 (en) | Stabilized ace inhibitor compositions | |
US5206264A (en) | Use of disulfiram to prevent cardiovascular damage | |
CA2355814C (en) | Pharmaceutical composition for ophthalmic use | |
SHILS | Experimental human magnesium depletion: I. Clinical observations and blood chemistry alterations | |
Sorenson et al. | Treatment of rheumatoid and degenerative diseases with copper complexes: a review with emphasis on copper-salicylate | |
US6191153B1 (en) | Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity | |
JPH11514629A (ja) | 安定な甲状腺ホルモン含有薬剤 | |
CA1048933A (en) | Pharmaceutical preparations for the treatment of hyperuricacidemia | |
US3196078A (en) | Process for combating retinits pigmentosa | |
Fine et al. | Malabsorption of frusemide caused by phenytoin. | |
US4914095A (en) | Use of imidazobenzodiazepines for psychotic disorders | |
Fleetham et al. | Silo-filler's disease. | |
KR101086040B1 (ko) | 간섬유화 및 간경화 치료 효과를 갖는 아시아트산 유도체 | |
HENCH | Gold salts for rheumatoid arthritis | |
US5192806A (en) | Method of preventing penile tissue degenerative change | |
Jacobsen et al. | 4-Methylpyrazole–present status | |
Clarke et al. | Confusion and paranoia associated with oral tocainide | |
US3894153A (en) | Method of medical treatment of asthma | |
Marley | Non-thrombocytopenic Purpura after Chlorpromazine | |
CN115671118B (zh) | 一种褐藻寡糖的用途 | |
US3627886A (en) | Methods of solubilizing coumermycin employing urea, dimethylacetamide or mixtures thereof | |
CN110664799B (zh) | 用于治疗脑缺血的药物组合物及其应用 | |
Borreli et al. | The co-operative action of hyaluronidase and urokinase on the isoproterenol-induced myocardial infarction in rats | |
US4105794A (en) | Process of mitigating cholelithiasis |